Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
A national lung cancer screening expansion, backed by the NCI, aims to boost early detection and reduce disparities across 60 U.S. sites.
A national study is expanding the QUILS™ lung cancer screening program to 60 U.S. sites, building on Kentucky’s success in boosting screening rates and reducing late-stage diagnoses.
Funded by the National Cancer Institute, the two-phase project, led by University of Kentucky and University of Colorado researchers, will refine the program and may include a four-year trial to identify key effective components.
The initiative supports patient eligibility, tobacco cessation, and shared decision-making.
Separately, a digital program called mPATH-Lung increased screening rates among over 26,000 high-risk smokers in North Carolina, with 24.5% completing scans within 16 weeks—up from 17% in the control group—across all demographic groups.
The digital tool, accessible via health portals or text, offers education, decision support, and online scheduling.
Both efforts aim to improve access to life-saving lung cancer screening and reduce disparities.
Una expansión nacional de detección de cáncer de pulmón, respaldada por el NCI, tiene como objetivo impulsar la detección temprana y reducir las disparidades en 60 sitios de los Estados Unidos.